Youth Nicotine Use: A Growing Public Health Concern

Nov.25.2022
Youth Nicotine Use: A Growing Public Health Concern
Teenagers in the US are increasingly using e-cigarettes and flavored tobacco products, leading to concerns of nicotine addiction.

According to data from the Centers for Disease Control and Prevention, approximately 1,600 young people in this country will try their first cigarette each day.


According to the 2022 National Youth Tobacco Survey, "3.7% of middle and high school students - about 1 million in total - have tried combustible tobacco products such as cigars or cigarettes," reported Ken Alltucker of USA Today. This isn't even their most popular choice. Survey data shows that e-cigarettes are by far the most popular choice for school-age children. During the study period from January 18 to May 31, "nearly 3.1 million middle and high school students tried e-cigarettes or other tobacco products." Among adolescent e-cigarette users, "85% said they use flavored e-cigarettes, with over half using disposable e-cigarettes.


The number of people using very specific tobacco products is much higher among certain groups, and this is not a coincidence," said Matthew L. Myers, President of the non-profit organization, the Campaign for Tobacco-Free Kids. "This is directly related to the advertising positioning of the tobacco industry.


It is truly concerning that 3 million children are using these products," added Erika Sward, Assistant Vice President for National Advocacy at the American Lung Association.


Seasoning products have fueled this epidemic from the beginning," said Dennis Henigan, Vice President of Law and Regulatory Affairs for the Campaign for Tobacco-Free Kids, to USA Today.


Flavored electronic cigarettes are causing a new generation of Americans to become addicted to nicotine," wrote Margaret Foti, CEO of the American Association for Cancer Research, in a recent STAT news op-ed.


In the past decade, there has been a significant increase in the number of teenagers, young adults, and individuals who have never previously used tobacco products, using flavored electronic cigarettes and other electronic nicotine delivery systems, reaching its peak among high school students in 2019," said Forte. "While the use of these products saw a decline during the COVID-19 pandemic, their popularity is once again on the rise.


According to a report by USA Today, although the US Food and Drug Administration issued a ban in 2020 prohibiting the use of flavor cartridges in e-cigarettes that deliver nicotine, the industry seems to have found a way around this regulation by selling lab-made nicotine instead of tobacco-made nicotine. Earlier this year, the FDA warned synthetic nicotine manufacturers and retailers about the illegal sale and marketing of these products.


Swod warned that, "Until we address the root causes - wholesalers, manufacturers, and distributors - we will continue in this cycle" of young people vaping.


Foti wrote: "Prohibiting flavored (electronic nicotine delivery systems) products would be a powerful strategy for reducing their appeal to young people, and reducing the appeal of these products must be an urgent public health priority.


In late October, the American Cancer Society and the American Society of Clinical Oncology released an updated joint policy statement calling for urgent action to prevent further nicotine addiction. "It includes a ban on all flavored electronic nicotine delivery system products and strengthened regulatory enforcement," she added. The research cited by Foti suggests that young people who use these products are approximately three times more likely to start smoking traditional cigarettes than their peers who do not use them.


As cancer experts, we are increasingly concerned about the growing use of electronic nicotine delivery systems, as adolescents and young people who may not have used traditional tobacco products are now using these devices and risking addiction to nicotine, which in turn could lead to long-term use of combustible tobacco," she added.


According to an article on NewsForKids.net, a platform created by teachers to inform children about news, the problems caused by e-cigarettes could last a lifetime for those who have never smoked before. In the US, cigarettes and e-cigarettes can only be sold to adults, but many companies are attempting to lure young people into trying e-cigarettes by using flavors such as candy or cotton candy, making the e-liquid look like children's juice or candy. Therefore, many young people are starting to use e-cigarettes, believing them to be safe.


It is dangerous for young people's brain development to be exposed to nicotine. The Mayo Clinic states that for some individuals, any amount of tobacco use can quickly lead to nicotine addiction. This is the reality our children are facing.


Statement:


This article is compiled from third-party information and is intended for industry-related communication and learning purposes only.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The translation of this article is only intended for industry exchange and research purposes.


Due to limitations in the translator's ability, the translated article may not fully convey the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS is fully aligned with the Chinese government's position on any domestic, Hong Kong, Macau, Taiwan or foreign-related issues and statements.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
SMOORE-owned vaping brand VAPORESSO introduced the VAST refillable open-system vape in October 2026, featuring Tri-Core Mesh technology that integrates three resistance configurations—0.8Ω, 0.6Ω and 0.4Ω—within a single pod. The device supports different operating modes and e-liquid types. The standard version features a 10mL pod, while a TPD-labelled configuration combines a 2mL pod with an 8mL refill container. The device has a 1,600mAh battery and a maximum output of 30W. VAPORESSO claims up to six pod refills and a tested coil lifespan of up to 150,000 puffs. The UK's MHRA published a related device notification on October 12. The official MSRP is $25.90, compared with a $35.90 listing on VAPORESSO's direct store.
product
Oct.30
Ukraine Raises Excise Stamp Fees for Tobacco, Heated Tobacco and Vape Liquids by 30.5% as Parliament Backs E-Excise Delay to 2027
Ukraine Raises Excise Stamp Fees for Tobacco, Heated Tobacco and Vape Liquids by 30.5% as Parliament Backs E-Excise Delay to 2027
Ukraine's Cabinet of Ministers adopted Resolution No. 1259 on October 15, 2026, increasing excise stamp production fees for tobacco products and e-cigarette liquids by approximately 30.5%, from UAH 0.1643 to UAH 0.2144 per stamp. Fees for alcoholic beverages rose by about 30.2%. Separately, Ukraine's parliament passed Bill No. 15532 on October 13, proposing to postpone the full implementation of electronic excise stamps and traceability for alcohol, tobacco and e-cigarette liquids from November 1, 2026, to July 1, 2027. Parliament cited additional testing, configuration and integration requirements. The bill was sent to the president for signature on October 19.
Regulations
Oct.21
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Pennsylvania began enforcing its electronic nicotine delivery system directory restrictions on October 19, 2026. Among 163 product listings recorded before enforcement, four CrossBar 20K disposables stood out with 13mL capacity, advertised puff counts of up to 20,000 and a flattened design distinct from conventional pod systems and compact disposables. Historical records identify earlier 1.3mL CrossBar products associated with Romo LLC, while newer 13mL products appeared in several state directories beginning in 2025 under entities including Blue Nine LLC. PMTA compliance expert Mr. K identified amendments and application ownership transfers as possible regulatory mechanisms, although neither has been confirmed in this case. Separately, Reynolds' $7.5 million acquisition of 16 PACHA products and related assets illustrates the commercial value of products linked to historic PMTA submissions.
Special Report
Oct.22
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
French vaping company Kumulus Vape reported first-half 2026 revenue of €25.5 million, down 8.3% year over year, as its core B2B distribution business fell 11% to €21.6 million. B2C and store-network revenue rose 5.6% and 17.8%, respectively. Commercial margin increased to 26.3% from 21.7%, while net profit rose 24.1% to €0.8 million. The company attributed the profitability improvement to catalog optimization, logistics restructuring and the ramp-up of Labster, its in-house production unit for proprietary brands.
Market
Sep.17 by 2Firsts Perspectives